$LGYV
LEGACY VENTURES INTERNATIONAL INC.

2024 Q1 Form 10-Q Financial Statement

#000149315224023791 Filed on June 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $6.810K $10.77K $10.99K
YoY Change -38.03% -35.85% 30.83%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $6.810K $10.77K $10.99K
YoY Change -38.03% -35.85% 30.83%
Operating Profit -$10.77K -$10.99K
YoY Change -35.87% 30.82%
Interest Expense $10.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $5.00
YoY Change
Pretax Income -$6.807K -$10.77K -$10.99K
YoY Change -38.03% -35.89% 30.77%
Income Tax
% Of Pretax Income
Net Earnings -$6.807K -$10.77K -$10.99K
YoY Change -38.03% -35.89% 30.77%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 50.32M shares 50.32M shares 50.32M shares
Diluted Shares Outstanding 50.32M shares 50.32M shares 50.32M shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $840.00 $840.00 $2.040K
YoY Change -58.82% 133.33%
Cash & Equivalents $842.00 $842.00 $2.040K
Short-Term Investments
Other Short-Term Assets $0.00 $510.00 $510.00
YoY Change -100.0% 0.0%
Inventory
Prepaid Expenses $509.00 $509.00
Receivables
Other Receivables
Total Short-Term Assets $840.00 $1.350K $2.550K
YoY Change -67.06% 55.17%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $1.00 -$1.00
YoY Change -100.0% -120.0%
TOTAL ASSETS
Total Short-Term Assets $840.00 $1.350K $2.550K
Total Long-Term Assets $0.00 $1.00 -$1.00
Total Assets $840.00 $1.351K $2.549K
YoY Change -67.05% 56.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $20.84K $14.03K $17.88K
YoY Change 16.55% 14.91% -82.19%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $97.74K $91.45K $50.85K
YoY Change 92.21% 139.52% -54.56%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $97.74K $91.45K $50.85K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $97.74K $91.45K $50.85K
YoY Change 92.23% 139.53% -54.56%
SHAREHOLDERS EQUITY
Retained Earnings -$6.532M -$6.525M -$6.483M
YoY Change 0.75% 0.82%
Common Stock $5.032K $5.032K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$96.90K -$90.10K -$48.30K
YoY Change
Total Liabilities & Shareholders Equity $840.00 $1.351K $2.549K
YoY Change -67.05% 56.18%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023 Q1
OPERATING ACTIVITIES
Net Income -$6.807K -$10.77K -$10.99K
YoY Change -38.03% -35.89% 30.77%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $510.00 -$32.24K $1.680K
YoY Change -69.64% 686.34%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -520.0 32.25K 0.000
YoY Change
NET CHANGE
Cash From Operating Activities 510.0 -32.24K 1.680K
Cash From Investing Activities
Cash From Financing Activities -520.0 32.25K 0.000
Net Change In Cash -10.00 10.00 1.680K
YoY Change -100.6% -100.24%
FREE CASH FLOW
Cash From Operating Activities $510.00 -$32.24K $1.680K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Entity Central Index Key
EntityCentralIndexKey
0001616788
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50315064 shares
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
usd
CY2024Q1 LGYV Bank Charges And Other
BankChargesAndOther
usd
LGYV Bank Charges And Other
BankChargesAndOther
usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50315064 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50315064 shares
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
5 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
5 usd
LGYV Bank Charges And Other
BankChargesAndOther
-150 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-150 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6807 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10985 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-24319 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-37593 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-6807 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-10985 usd
us-gaap Net Income Loss
NetIncomeLoss
-24319 usd
us-gaap Net Income Loss
NetIncomeLoss
-37593 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50315064 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50315064 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50315064 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50315064 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50315064 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50315064 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50315064 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50315064 shares
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-9813 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-20517 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-16795 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-37312 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-10985 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-48297 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-72583 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-6744 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-79327 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-10768 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-90095 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-90095 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-6807 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-96902 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-96902 usd
us-gaap Net Income Loss
NetIncomeLoss
-24319 usd
us-gaap Net Income Loss
NetIncomeLoss
-37593 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-509 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
509 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-17759 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2370 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-41569 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-40472 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
40733 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
21495 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
40733 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
21495 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-836 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-18977 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1678 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
21017 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
842 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2040 usd
CY2024Q1 LGYV Working Capital Deficit
WorkingCapitalDeficit
96902 usd
CY2023Q2 LGYV Working Capital Deficit
WorkingCapitalDeficit
72583 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6531705 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6507386 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
40733 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
21495 usd
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50315064 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50315064 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50315064 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50315064 shares

Files In Submission

Name View Source Status
0001493152-24-023791-index-headers.html Edgar Link pending
0001493152-24-023791-index.html Edgar Link pending
0001493152-24-023791.txt Edgar Link pending
0001493152-24-023791-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
lgyv-20240331.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lgyv-20240331_cal.xml Edgar Link unprocessable
lgyv-20240331_def.xml Edgar Link unprocessable
lgyv-20240331_lab.xml Edgar Link unprocessable
lgyv-20240331_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending